Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Biotech
Adjuvia Therapeutics Raises $8 Million to Advance Mitochondrial Disease Drug
Life Sciences Times
-
July 29, 2026
0
Biotech
CORE Biomedicine Raises $21 Million to Advance Precision Cancer Therapies
Life Sciences Times
-
July 28, 2026
0
Venture Capital
AdvanCell Raises $315 Million to Advance Targeted Alpha Cancer Therapies
Life Sciences Times
-
July 15, 2026
0
Venture Capital
Draig Therapeutics Raises $65 Million to Advance Neuropsychiatric Drug Pipeline
Life Sciences Times
-
July 14, 2026
0
Venture Capital
Pediatrica Health Group Raises $28 Million to Expand Pediatric Primary Care
Life Sciences Times
-
July 7, 2026
0
Venture Capital
Novartis to Acquire Sofinnova-Backed Myricx Bio in Deal Worth Up to $1.5 Billion
Life Sciences Times
-
July 6, 2026
0
Medtech
Anodyne Nanotech Raises $12.6 Million to Advance Weekly GLP-1 Patch
Life Sciences Times
-
June 24, 2026
0
Venture Capital
CroĂValve Raises Additional $27 Million to Expand DUO Adapt Study
Life Sciences Times
-
June 23, 2026
0
Venture Capital
Rejoni Secures $25 Million to Advance Juveena Hydrogel System Toward FDA Approval
Life Sciences Times
-
June 16, 2026
0
Venture Capital
SonoThera Raises $125 Million to Advance Nonviral Genetic Medicine Programs
Life Sciences Times
-
June 11, 2026
0
Venture Capital
QT Imaging Prices $10 Million Public Offering
Life Sciences Times
-
May 15, 2026
0
Biotech
CellCentric Raises $220 Million to Advance Multiple Myeloma Drug Trials
Life Sciences Times
-
May 6, 2026
0
1
2
3
...
115
Page 2 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026